Evidence
Heliyon. 2023 Oct 14;9(10):e21067. doi: 10.1016/j.heliyon.2023.e21067. eCollection 2023 Oct.
ABSTRACT
It is challenging to manage schizophrenic catatonia and comorbid chronic intestinal pseudo-obstruction (CIPO). The pathology of catatonia is unclear. There are few reports or research on this issue. In this case, we present a middle-aged woman diagnosed with schizophrenia with catatonic features and comorbid CIPO. In the treatment process, modified electroconvulsive therapy (mECT) improved her stupor and CIPO partially. Lorazepam alleviated her stupor and CIPO completely. It is the first report describing complete remission with lorazepam in patient suffering from comorbid schizophrenic catatonia and CIPO, which may benefit the exploration of pathophysiology and treatment of comorbidity of schizophrenia with catatonia and CIPO.
PMID:37916112 | PMC:PMC10616325 | DOI:10.1016/j.heliyon.2023.e21067
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
A case of comorbidity of schizophrenic catatonia and chronic intestinal pseudo-obstruction Successfully managed with lorazepam
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Evidence Blueprint
A case of comorbidity of schizophrenic catatonia and chronic intestinal pseudo-obstruction Successfully managed with lorazepam
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
A case of comorbidity of schizophrenic catatonia and chronic intestinal pseudo-obstruction Successfully managed with lorazepam
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
